Evidence map›Paper›PMID 39801472›Full record

ArticleCirculation. Cardiovascular quality and outcomes2025

Predicting Mortality in Patients Hospitalized With Acute Myocardial Infarction: From the National Cardiovascular Data Registry.

Kamil F Faridi, Yongfei Wang, Karl E Minges, Nathaniel R Smilowitz, Robert L McNamara, Michael C Kontos, Tracy Y Wang, Annie C Connors, Julie M Clary, Anwar D Osborne and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kamil F FaridiSection of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., Y.W., K.E.M., R.L.M.N., J.P.C.).ORCID 0000-0002-9276-9110
Yongfei WangSection of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., Y.W., K.E.M., R.L.M.N., J.P.C.).ORCID 0000-0001-5764-2213
Karl E MingesSection of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., Y.W., K.E.M., R.L.M.N., J.P.C.).ORCID 0000-0002-9063-8272
Nathaniel R SmilowitzDivision of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY (N.R.S.).ORCID 0000-0002-6823-2815
Robert L McNamaraSection of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., Y.W., K.E.M., R.L.M.N., J.P.C.).ORCID 0000-0002-1364-7749
Michael C KontosDivision of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, VA (M.C.K.).
Tracy Y WangDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.Y.W.).
Annie C ConnorsDivision of Cardiology, Tufts Medical Center, Boston, MA (A.C.C.).
Julie M ClaryDivision of Cardiology, Indiana University School of Medicine, Indianapolis (J.M.C.).
Anwar D OsborneDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA (A.D.O.).ORCID 0000-0001-8235-2330
Lucy PereiraCenter for Outcomes Research and Evaluation, Yale New Haven Health, New Haven, CT (K.F.F., Y.W., K.E.M., R.L.M.N., L.P., J.P.C.).
Jeptha P CurtisSection of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., Y.W., K.E.M., R.L.M.N., J.P.C.).ORCID 0000-0002-6872-0501
Kristina BlankinshipAmerican College of Cardiology, Washington DC (K.B., J.M.).ORCID 0009-0007-8355-0882
Jarrott MayfieldAmerican College of Cardiology, Washington DC (K.B., J.M.).
J Dawn AbbottDivision of Cardiology Lifespan Cardiovascular Institute, Warren Alpert Medical School of Brown University, Providence, RI (J.D.A.).ORCID 0000-0002-2560-0155

Funding

Optimizing Available Data Sources for Post-Marketing Surveillance: Real-World Use of Left Atrial Appendage OcclusionK23HL161424 · NHLBI · YALE UNIVERSITY · PI Kamil Faridi · 2022 to 2026
$950k
Mechanisms of Coronary Microvascular DiseaseK23HL150315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMILOWITZ, NATHANIEL ROSSO · 2020 to 2024
$948k
NHLBI NIH HHS K23 HL150315NHLBI NIH HHS K23 HL161424
6 · The paper itself

Abstract

backgroundIn-hospital mortality risk prediction is an important tool for benchmarking quality and patient prognostication. Given changes in patient characteristics and treatments over time, a contemporary risk model for patients with acute myocardial infarction (MI) is needed.

methodsData from 313 825 acute MI hospitalizations between January 2019 and December 2020 for adults aged ≥18 years at 784 sites in the National Cardiovascular Data Registry Chest Pain-MI Registry were used to develop a risk-standardized model to predict in-hospital mortality. The sample was randomly divided into 70% development (n=220 014) and 30% validation (n=93 811) samples, and 23 separate registry-based patient characteristics at presentation were considered for model inclusion using stepwise logistic regression with 1000 bootstrapped samples. A simplified risk score was also developed for individual risk stratification.

resultsThe mean age of the study cohort was 65.3 (SD 13.1) years, and 33.6% were women. The overall in-hospital mortality rate was 5.0% (n=15 822 deaths). The final model included 14 variables, with out-of-hospital cardiac arrest, cardiogenic shock, and ST-segment elevation MI as the strongest independent predictors of mortality. The model also included age, comorbidities (dyslipidemia, diabetes, prior percutaneous coronary intervention, cerebrovascular disease, and peripheral artery disease), heart failure on admission, heart rate, systolic blood pressure, glomerular filtration rate, and hemoglobin. The model demonstrated excellent discrimination (C-statistic, 0.868 [95% CI 0.865-0.871]) and good calibration, with similar performance across subgroups based on MI type, periods before and during the COVID-19 pandemic, and hospital volume. The simplified risk score included values from 0 to 25, with mortality risk ranging from 0.3% with a score of 0 to 1 up to 49.4% with a score >11.

conclusionsThis contemporary risk model accurately predicts in-hospital mortality for patients with acute MI and can be used for risk standardization across hospitals and at the bedside for patient prognostication.

Indexed as

Decision Support TechniquesHospitalizationHospital MortalityMyocardial InfarctionAgedAged, 80 and overFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisRegistriesReproducibility of ResultsRisk AssessmentRisk Factorsmortality riskmyocardial infarctionquality of health care

Identifiers

PMID39801472
PMCPMC11919567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.